Stockscreener 앱 받기
90.99
2.49%
-2.03
전일 마감가:
$93.02
열려 있는:
$91.67
하루 거래량:
387.41K
Relative Volume:
0.81
시가총액:
$6.06B
수익:
-
순이익/손실:
$-224.29M
주가수익비율:
-23.33
EPS:
-3.9
순현금흐름:
$-185.06M
1주 성능:
-10.39%
1개월 성능:
+7.69%
6개월 성능:
+17.09%
1년 성능:
+1.31%
1일 변동 폭
$90.50
$93.61
1주일 범위
$90.50
$104.90
52주 변동 폭
$55.53
$104.90
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
NUVL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
90.83 | 6.76B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.71 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.74 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.64 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.63 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-10-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-09-03 | 개시 | Raymond James | Outperform |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-03-14 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-10-24 | 개시 | UBS | Neutral |
| 2024-08-29 | 개시 | Barclays | Overweight |
| 2024-04-17 | 개시 | Jefferies | Buy |
| 2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | 재개 | Guggenheim | Buy |
| 2024-02-23 | 개시 | Robert W. Baird | Outperform |
| 2023-09-27 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | SVB Securities | Market Perform |
| 2023-07-24 | 개시 | Guggenheim | Buy |
| 2023-01-18 | 개시 | Wedbush | Outperform |
| 2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Will Nuvalent Inc. bounce back from current support2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com
Can Nuvalent Inc. stock maintain growth trajectoryMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com
How Nuvalent Inc. stock trades during market volatilityMarket Growth Review & Free Reliable Trade Execution Plans - newser.com
Will Nuvalent Inc. stock rally after Fed decisionsQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com
How risky is Nuvalent Inc. stock now2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Can Nuvalent Inc. stock outperform in 2025 bull market2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Why Nuvalent Inc. stock remains resilientJuly 2025 Market Mood & Target Return Focused Picks - newser.com
What momentum indicators show for Nuvalent Inc. stockTrade Ideas & Long Hold Capital Preservation Tips - newser.com
Why analysts remain bullish on Nuvalent Inc. stockMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Statistical indicators supporting Nuvalent Inc.’s strengthWall Street Watch & Technical Entry and Exit Alerts - newser.com
Published on: 2025-11-02 23:09:14 - newser.com
Can volume confirm reversal in Nuvalent Inc.Trade Risk Summary & Daily Technical Forecast Reports - newser.com
What data driven models say about Nuvalent Inc.’s futureTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
Using economic indicators to assess Nuvalent Inc. potentialBond Market & Real-Time Stock Price Movement Reports - newser.com
Custom strategy builders for tracking Nuvalent Inc.2025 Market Overview & Real-Time Volume Analysis - newser.com
Nuvalent, Inc. Reports Q3 2025 Progress and Financials - MSN
Published on: 2025-11-02 03:40:29 - newser.com
Barclays Maintains Nuvalent (NUVL) Overweight Recommendation - MSN
Nuvalent (NASDAQ:NUVL) Insider Deborah Ann Miller Sells 21,800 Shares - MarketBeat
Applying sector rotation models to Nuvalent Inc.Weekly Trading Summary & Pattern Based Trade Signal System - newser.com
Piper Sandler Maintains Nuvalent (NUVL) Overweight Recommendation - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Centene (CNC) and Nuvalent (NUVL) - The Globe and Mail
Nuvalent Inc Reports Q3 2025 EPS of -$1.70, Missing Estimates; S - GuruFocus
What moving averages say about Nuvalent Inc.July 2025 Update & Breakout Confirmation Trade Signals - newser.com
Nuvalent price target raised to $132 from $114 at UBS - MSN
Nuvalent price target raised to $120 from $105 at Goldman Sachs - TipRanks
Nuvalent (NASDAQ:NUVL) Announces Earnings Results - MarketBeat
Barclays Raises Price Target for Nuvalent (NUVL) to $112.00 | NU - GuruFocus
Nuvalent Executives Sell Shares Under Trading Plans - TradingView
NUVL insider trades: 4,000 options exercised, 4,000 shares sold - Stock Titan
[Form 4] Nuvalent, Inc. Insider Trading Activity - Stock Titan
UBS Adjusts Price Target on Nuvalent to $132 From $114, Maintains Buy Rating - MarketScreener
Nuvalent stock price target raised to $132 by UBS on cancer drug progress - Investing.com Canada
Analysts Are Bullish on Top Healthcare Stocks: TransMedics Group (TMDX), Nuvalent (NUVL) - The Globe and Mail
Why Nuvalent Inc. stock is trending among retail traders2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com
Decoding Nuvalent Inc (NUVL): A Strategic SWOT Insight - GuruFocus
Insider Selling: Nuvalent (NASDAQ:NUVL) Director Sells $1,437,799.35 in Stock - MarketBeat
Insider Selling: Nuvalent (NASDAQ:NUVL) Director Sells 32,455 Shares of Stock - MarketBeat
Nuvalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nuvalent Inc 주식 (NUVL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Noci Darlene | Chief Development Officer |
Oct 30 '25 |
Sale |
102.92 |
4,000 |
411,661 |
48,034 |
| Miller Deborah Ann | Chief Legal Officer |
Oct 30 '25 |
Option Exercise |
6.89 |
21,800 |
150,202 |
70,886 |
| Miller Deborah Ann | Chief Legal Officer |
Oct 30 '25 |
Sale |
103.16 |
21,800 |
2,248,943 |
49,086 |
1.29%
0.56%
자본화:
|
볼륨(24시간):